Introduction to SGLT2 Inhibition

February 6, 2014 12:10 pm

The management of Type 2 Diabetes (T2D) is complex and challenging.

Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments.

Find out more about SGLT2 inhibition and its potential impact on T2D management.

Category: News
About The Author
-
Next

Medication adherence in Malaysian patients with T2D – Video abstract 81612

Related Videos

Unleashing-the-Truth-How-to-Put-T2D-Patients-Hearts-First

Unleashing the Truth: How to Put T2D Patients’ Hearts First

PILA-PHARMA

PILA PHARMA

Cardiologists-Perspective-of-Diabetes-and-Cardiovascular-Risk-Management-in-Post-ACS-T2D-patients

Cardiologist’s Perspective of Diabetes and Cardiovascular Risk Management in Post-ACS T2D patients

Sodium-Glucose-Transporter-2-Inhibition-An-Important-Advancement-for-Patients-with-T2D-and-CKD

Sodium-Glucose Transporter-2 Inhibition: An Important Advancement for Patients with T2D and CKD

Type-2-Diabetes-Treatments-1

A Data Integration Multi-Omics Approach to Study Calorie Restriction-Induced Changes in Insulin Sensitivity

2038018

The Role of Nutrition in the Prevention and Intervention of Type 2 Diabetes